Roche’s Alzheimer’s Prevention Initiative study of crenezumab in autosomal dominant Alzheimer’s disease fails to meet co-primary endpoints
Roche’s Alzheimer’s Prevention Initiative study of crenezumab in autosomal dominant Alzheimer’s disease fails to meet co-primary endpoints: Basel Friday, June 17, 2022, 15:0 ...